Seven questions about osteopenia;Siete preguntas sobre la osteopenia

Medicina Clinica

Volumn 131, Issue 4, 2008, Pages 136-140

  Riancho, José A ^a   Hernández, José L ^a   González Macías, Jesús ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

COMPUTER ASSISTED TOMOGRAPHY; DENSITOMETRY; HUMAN; OSTEOPENIA; OSTEOPOROSIS; PREVALENCE; REVIEW; ULTRASOUND;

EID: 47049125111     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1157/13124102     Document Type: Article

References (24)

1. Kanis JA, WHO study group. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. Osteoporos Int. 1994;4:368-81.
2. Masud T, Mootoosamy I, McCloskey EV, O'Sullivan MP, Whitby EP, King D, et al. Assessment of osteopenia from spine radiographs using two different methods: the Chingford study. Br J Radiol. 1996;69:451-6.
3. Díaz Curiel M, García JJ, Carrasco JL, Honorato J, Pérez Cano R, Rapado A, et al. Prevalencia de osteoporosis determinada por densitometría en la población femenina española. Med Clin (Barc). 2001;116:86-8.
4. Johnell O, Kanis JA, Oden A, Johansson H, De Laet C, Delmas P, et al. Predictive value of BMD for hip and other fractures. J Bone Miner Res. 2005;20:1185-94.
5. Siris ES, Genant HK, Laster AJ, Chen P, Misurski DA, Krege JH. Enhanced prediction of fracture risk combining vertebral fracture status and BMD. Osteoporos Int. 2007;18:761-70.
6. Cranney A, Jamal SA, Tsang JF, Josse RG, Leslie WD. Low bone mineral density and fracture burden in postmenopausal women. Can Med Ass J. 2007;177:575-80.
7. Pasco JA, Seeman E, Henry MJ, Merriman EN, Nicholson GC, Kotowicz MA. The population burden of fractures originates in women with osteopenia, not osteoporosis. Osteoporos Int. 2006;17:1404-9.
8. Kanis JA, Borgstrom F, De Laet C, Johansson H, Johnell O, Jonsson B, et al. Assessment of fracture risk. Osteoporos Int. 2005;16:581-9.
9. Kanis JA, Johnell O, De Laet C, Johansson H, Oden A, Delmas P, et al. A meta-analysis of previous fracture and subsequent fracture risk. Bone. 2004;35:375-82.
10. Miller PD, Barlas S, Brenneman SK, Abbott TA, Chen YT, Barrett-Connor E, et al. An approach to identifying osteopenic women at increased short-term risk of fracture. Arch Intern Med. 2004;164:1113-20.
11. Sornay-Rendu E, Muñoz F, Garnero P, Duboeuf F, Delmas PD. Identification of osteopenic women at high risk of fracture: the OFELY study. J Bone Miner Res. 2005;20:1813-9.
12. Sambrook P, Cooper C. Osteoporosis. Lancet. 2006;367:2010-8.
13. Kanis JA, Johnell O, Black DM, Downs RW Jr, Sarkar S, Fuerst T, et al. Effect of raloxifene on the risk of new vertebral fracture in postmenopausal women with osteopenia or osteoporosis: a reanalysis of the Multiple Outcomes of Raloxifene Evaluation trial. Bone. 2003;33:293-300.
14. Quandt SA, Thompson DE, Schneider DL, Nevitt MC, Black DM. Effect of alendronate on vertebral fracture risk in women with bone mineral density T scores of -1.6 to -2.5 at the femoral neck: the Fracture Intervention Trial. Mayo Clin Proc. 2005;80:343-9.
15. Siris ES, Simon JA, Barton IP, McClung MR, Grauer A. Effects of risedronate on fracture risk in postmenopausal women with osteopenia. Osteoporos Int. 2008;19:681-6.
16. Seeman E, Devogelaer J, Lorenc R, Spector T, Brixen K, Balogh A, et al. Strontium ranelate reduces the risk of vertebral fractures in patients with osteopenia. J Bone Miner Res. 2008;23:433-8.
17. Schousboe JT, Nyman JA, Kane RL, Ensrud KE. Cost-effectiveness of alendronate therapy for osteopenic postmenopausal women. Ann Intern Med. 2005;142:734-41.
18. Meadows ES, Klein R, Rousculp MD, Smolen L, Ohsfeldt RL, Johnston JA. Cost-effectiveness of preventative therapies for postmenopausal women with osteopenia. BMC Womens Health. 2007;7:6.
19. Kanis JA, Johnell O, De Laet C, Jonsson B, Oden A, Ogelsby AK. International variations in hip fracture probabilities: implications for risk assessment. J Bone Miner Res. 2002;17:1237-44.
20. McClung MR. Osteopenia: to treat or not to treat? Ann Intern Med. 2005;142:796-7.
21. Cummings SR. A 55-year-old woman with osteopenia. JAMA. 2006;296:2601-10.
22. Khosla S, Melton LJ III. Clinical practice. Osteopenia. N Engl J Med. 2007;356:2293-300.
23. Black DM, Steinbuch M, Palermo L, Dargent-Molina P, Lindsay R, Hoseyni MS, et al. An assessment tool for predicting fracture risk in postmenopausal women. Osteoporos Int. 2001;12:519-28.
24. Sosa M, Grupo de trabajo de osteoporosis de la SEMI. Guía de prevención y tratamiento de la osteoporosis inducida por glucocorticoides. Madrid: Medical & Marketing Communications; 2007.